Please use this identifier to cite or link to this item:
https://doi.org/10.21256/zhaw-25365
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Grobet, Cécile | - |
dc.contributor.author | Audigé, Laurent | - |
dc.contributor.author | Eichler, Klaus | - |
dc.contributor.author | Meier, Flurina | - |
dc.contributor.author | Marks, Miriam | - |
dc.contributor.author | Herren, Daniel B. | - |
dc.date.accessioned | 2022-07-27T09:25:03Z | - |
dc.date.available | 2022-07-27T09:25:03Z | - |
dc.date.issued | 2022 | - |
dc.identifier.issn | 0363-5023 | de_CH |
dc.identifier.issn | 1531-6564 | de_CH |
dc.identifier.uri | https://digitalcollection.zhaw.ch/handle/11475/25365 | - |
dc.description.abstract | Purpose: Knowledge about the costs and benefits of hand surgical interventions is important for surgeons, payers, and policy makers. Little is known about the cost-effectiveness of surgery for thumb carpometacarpal osteoarthritis. The objective of this study was to examine patients’ quality of life and economic costs, with focus on the cost-utility ratio 1 year after surgery for thumb carpometacarpal osteoarthritis compared with that for continued nonsurgical management. Methods: Patients with thumb carpometacarpal osteoarthritis indicated for resection arthroplasty were included in a prospective study. The quality of life (using European Quality of Life-5 Dimensions-5 Level), direct medical costs, and productivity losses were assessed up to 1 year after surgery. Baseline data at recruitment and costs sustained over 1 year before surgery served as a proxy for nonsurgical management. The total costs to gain 1 extra quality-adjusted life year and the incremental cost-effectiveness ratio were calculated from a health care system and a societal perspective. Results: The mean European Quality of Life-5 Dimensions-5 Level value for 151 included patients improved significantly from 0.69 to 0.88 (after surgery). The productivity loss during the preoperative period was 47% for 49 working patients, which decreased to 26% 1 year after surgery. The total costs increased from US $20,451 in the preoperative year to US $24,374 in the postoperative year. This resulted in an incremental cost-effectiveness ratio of US $25,370 per quality-adjusted life year for surgery compared with that for simulated nonsurgical management. Conclusions: The calculated incremental cost-effectiveness ratio was clearly below the suggested Swiss threshold of US $92,000, indicating that thumb carpometacarpal surgery is a cost-effective intervention. | de_CH |
dc.language.iso | en | de_CH |
dc.publisher | Elsevier | de_CH |
dc.relation.ispartof | Journal of Hand Surgery (American Volume) | de_CH |
dc.rights | https://creativecommons.org/licenses/by-nc-nd/4.0/ | de_CH |
dc.subject | Cost-effectiveness | de_CH |
dc.subject | Cost-utility | de_CH |
dc.subject | Quality of life | de_CH |
dc.subject | Thumb carpometacarpal osteoarthritis | de_CH |
dc.subject.ddc | 362.1041: Gesundheitsökonomie | de_CH |
dc.subject.ddc | 617.5: Orthopädische Chirurgie | de_CH |
dc.title | Cost-utility analysis of thumb carpometacarpal resection arthroplasty : a health economic study using real-world data | de_CH |
dc.type | Beitrag in wissenschaftlicher Zeitschrift | de_CH |
dcterms.type | Text | de_CH |
zhaw.departement | School of Management and Law | de_CH |
zhaw.organisationalunit | Winterthurer Institut für Gesundheitsökonomie (WIG) | de_CH |
dc.identifier.doi | 10.1016/j.jhsa.2022.01.013 | de_CH |
dc.identifier.doi | 10.21256/zhaw-25365 | - |
dc.identifier.pmid | 35346526 | de_CH |
zhaw.funding.eu | No | de_CH |
zhaw.issue | 5 | de_CH |
zhaw.originated.zhaw | Yes | de_CH |
zhaw.pages.end | 453 | de_CH |
zhaw.pages.start | 445 | de_CH |
zhaw.publication.status | acceptedVersion | de_CH |
zhaw.volume | 47 | de_CH |
zhaw.embargo.end | 2023-05-01 | de_CH |
zhaw.publication.review | Peer review (Publikation) | de_CH |
zhaw.author.additional | No | de_CH |
zhaw.display.portrait | Yes | de_CH |
Appears in collections: | Publikationen School of Management and Law |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
2022_Grobet-etal_Cost-utility-analysis-thumb-carpometacarpal.pdf | 525.28 kB | Adobe PDF | View/Open |
Show simple item record
Grobet, C., Audigé, L., Eichler, K., Meier, F., Marks, M., & Herren, D. B. (2022). Cost-utility analysis of thumb carpometacarpal resection arthroplasty : a health economic study using real-world data. Journal of Hand Surgery (American Volume), 47(5), 445–453. https://doi.org/10.1016/j.jhsa.2022.01.013
Grobet, C. et al. (2022) ‘Cost-utility analysis of thumb carpometacarpal resection arthroplasty : a health economic study using real-world data’, Journal of Hand Surgery (American Volume), 47(5), pp. 445–453. Available at: https://doi.org/10.1016/j.jhsa.2022.01.013.
C. Grobet, L. Audigé, K. Eichler, F. Meier, M. Marks, and D. B. Herren, “Cost-utility analysis of thumb carpometacarpal resection arthroplasty : a health economic study using real-world data,” Journal of Hand Surgery (American Volume), vol. 47, no. 5, pp. 445–453, 2022, doi: 10.1016/j.jhsa.2022.01.013.
GROBET, Cécile, Laurent AUDIGÉ, Klaus EICHLER, Flurina MEIER, Miriam MARKS und Daniel B. HERREN, 2022. Cost-utility analysis of thumb carpometacarpal resection arthroplasty : a health economic study using real-world data. Journal of Hand Surgery (American Volume). 2022. Bd. 47, Nr. 5, S. 445–453. DOI 10.1016/j.jhsa.2022.01.013
Grobet, Cécile, Laurent Audigé, Klaus Eichler, Flurina Meier, Miriam Marks, and Daniel B. Herren. 2022. “Cost-Utility Analysis of Thumb Carpometacarpal Resection Arthroplasty : A Health Economic Study Using Real-World Data.” Journal of Hand Surgery (American Volume) 47 (5): 445–53. https://doi.org/10.1016/j.jhsa.2022.01.013.
Grobet, Cécile, et al. “Cost-Utility Analysis of Thumb Carpometacarpal Resection Arthroplasty : A Health Economic Study Using Real-World Data.” Journal of Hand Surgery (American Volume), vol. 47, no. 5, 2022, pp. 445–53, https://doi.org/10.1016/j.jhsa.2022.01.013.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.